PARIS, February 1, 2002 (LSN.ca) – Evidence that abortifacient morning-after pills are sweeping the globe comes from one of the companies which manufacturers the abortifacient drugs. HRA Pharma which markets the abortifacient morning after pill Norlevo, and also marketed as Vika, Vikela and Duofem, boasts on its website of the drugs availability in over 40 counties.
Beyond the listing on the website, LifeSite has learned that the company’s abortifacient drug has recently been allowed into Uganda as a pilot study in six districts with the Ministry of Health’s approval.
The website lists the following countries where their product is available: South Africa . Cameroon . Madagascar . Mauritius . Benin . Congo Brazaville . Congo Kinshasa . Guinea . Ivory Coast . Mauritania . Senegal . Gabon . Mali . India . Taëwan . Sri Lanka . South Korea . Brazil . Venezuela . Mexico . French Guyana . Peru . Colombia . Belgium . Finland . France . Netherlands . Greece . Dane . Luxembourg . Italy . Germany . Sweden . Norway . Austria . Balkan Countries . Portugal . Spain . Algeria . Morocco . Tunisia
See the HRA Pharma website at: https://www.norlevo.com